• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌骨转移的影像学:最新进展

Imaging of bone metastases in prostate cancer: an update.

作者信息

Langsteger W, Haim S, Knauer M, Waldenberger P, Emmanuel K, Loidl W, Wolf I, Beheshti M

机构信息

Department of Nuclear Medicine and Endocrinology, PET - CT Center Linz, Linz, Austria.

出版信息

Q J Nucl Med Mol Imaging. 2012 Oct;56(5):447-58.

PMID:23069924
Abstract

Assessing bone metastases is often beyond the scope of plain - film radiography, and nuclear imaging in particular with bone scintigraphy has proved the mainstay for detection of bony disease for over 40 years. Bone scanning with 99mTechnetium - labeled diphosphonates relies on the detection of pathological osteoblastic response elicited from malignant cells. This technique offers the advantage of whole body examination, low cost, availability and high sensitivity. However, it suffers from relative low specificity. The addition of single-photon emission computed tomography (SPECT) to bone scintigraphy has markedly improved the diagnostic benefit. Although the accuracy of SPECT is significantly higher than that of planar scintigraphy, there is still room for improvement of anatomic localization and morphological characterization, a limitation that has currently been mainly overcome with the upcoming of combined SPECT-CT (computed tomography). Positron emission tomography (PET), a modality with higher spatial resolution than that of SPECT can be particularly helpful in detecting small lesions. Moreover, PET imaging using various specific radiotracers has the advantage of detecting malignant disease in both bone and soft tissues. It is highly sensitive mainly in detecting early bone marrow as well as for diagnosing lytic bony metastases and can be also reliably used to monitor therapy response. In this review, we present the current role of SPECT and PET in the imaging of skeletal metastases from prostate cancer.

摘要

评估骨转移通常超出了普通X线摄影的范围,尤其是核成像中的骨闪烁显像在40多年来一直是检测骨病的主要手段。用99m锝标记的二膦酸盐进行骨扫描依赖于检测恶性细胞引发的病理性成骨细胞反应。该技术具有全身检查、成本低、可及性高和灵敏度高的优点。然而,它的相对特异性较低。在骨闪烁显像中添加单光子发射计算机断层扫描(SPECT)显著提高了诊断效益。尽管SPECT的准确性明显高于平面闪烁显像,但在解剖定位和形态特征描述方面仍有改进空间,目前随着SPECT-CT(计算机断层扫描)的出现,这一局限性已基本得到克服。正电子发射断层扫描(PET)是一种空间分辨率高于SPECT的成像方式,对检测小病灶特别有帮助。此外,使用各种特定放射性示踪剂的PET成像具有检测骨和软组织恶性疾病的优势。它在检测早期骨髓以及诊断溶骨性骨转移方面高度敏感,也可可靠地用于监测治疗反应。在本综述中,我们介绍了SPECT和PET在前列腺癌骨转移成像中的当前作用。

相似文献

1
Imaging of bone metastases in prostate cancer: an update.前列腺癌骨转移的影像学:最新进展
Q J Nucl Med Mol Imaging. 2012 Oct;56(5):447-58.
2
Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.杂项癌症(肺癌、甲状腺癌、肾癌、骨髓瘤和神经内分泌肿瘤):SPECT 和 PET 在骨转移成像中的作用。
Semin Nucl Med. 2009 Nov;39(6):416-30. doi: 10.1053/j.semnuclmed.2009.07.002.
3
Breast cancer: role of SPECT and PET in imaging bone metastases.乳腺癌:SPECT 和 PET 在骨转移成像中的作用。
Semin Nucl Med. 2009 Nov;39(6):408-15. doi: 10.1053/j.semnuclmed.2009.05.002.
4
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.高危前列腺癌患者骨转移的检测:99mTc-MDP平面骨闪烁显像、单视野和多视野SPECT、18F-氟化物PET以及18F-氟化物PET/CT。
J Nucl Med. 2006 Feb;47(2):287-97.
5
Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.检测骨病变的敏感性取决于解剖定位:平面骨闪烁显像与18F PET的比较。
J Nucl Med. 1999 Oct;40(10):1623-9.
6
18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.18F-氟化物正电子发射断层扫描及正电子发射断层扫描/计算机断层扫描
Semin Nucl Med. 2007 Nov;37(6):462-9. doi: 10.1053/j.semnuclmed.2007.07.002.
7
Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.全身扩散加权 MRI 与(18)F-NaF PET/CT 检测高危型前列腺癌患者骨转移的比较。
AJR Am J Roentgenol. 2012 Nov;199(5):1114-20. doi: 10.2214/AJR.11.8351.
8
F-NaF-PET/CT and Tc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.F-NaF-PET/CT与Tc-MDP骨闪烁显像在前列腺癌骨转移检测中的应用
Semin Nucl Med. 2016 Nov;46(6):491-501. doi: 10.1053/j.semnuclmed.2016.07.003. Epub 2016 Sep 13.
9
Position of nuclear medicine modalities in the diagnostic work-up of breast cancer.核医学模式在乳腺癌诊断检查中的地位。
Q J Nucl Med Mol Imaging. 2004 Jun;48(2):109-18.
10
Prostate cancer: role of SPECT and PET in imaging bone metastases.前列腺癌:SPECT 和 PET 在骨转移成像中的作用。
Semin Nucl Med. 2009 Nov;39(6):396-407. doi: 10.1053/j.semnuclmed.2009.05.003.

引用本文的文献

1
Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical.胃泌素释放肽受体(GRPR)靶向成像药物的稳定性评估与稳定化。
Molecules. 2019 Aug 8;24(16):2878. doi: 10.3390/molecules24162878.
2
Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups.不同风险组新诊断前列腺癌分期中的骨闪烁显像
Asia Ocean J Nucl Med Biol. 2019 Spring;7(2):149-152. doi: 10.22038/AOJNMB.2019.35768.1242.
3
Diagnosis of prostate cancer.前列腺癌的诊断。
Asian J Urol. 2019 Apr;6(2):129-136. doi: 10.1016/j.ajur.2018.11.007. Epub 2019 Feb 14.
4
Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.18F-氟氯维司在前列腺癌骨转移诊断中的性能。
Clin Nucl Med. 2018 Jul;43(7):e226-e231. doi: 10.1097/RLU.0000000000002130.
5
PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.前列腺癌中使用放射性标记胆碱的PET及PET/CT:对20年临床研究的批判性重新评估
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1751-1776. doi: 10.1007/s00259-017-3700-x. Epub 2017 Apr 14.
6
A urologist's perspective on prostate cancer imaging: past, present, and future.泌尿科医生视角下的前列腺癌影像学:过去、现在与未来。
Abdom Radiol (NY). 2016 May;41(5):805-16. doi: 10.1007/s00261-016-0751-6.
7
Current Status of Hybrid PET/MRI in Oncologic Imaging.PET/MRI 融合成像在肿瘤影像学中的现状
AJR Am J Roentgenol. 2016 Jan;206(1):162-72. doi: 10.2214/AJR.15.14968. Epub 2015 Oct 22.
8
Imaging and evaluation of patients with high-risk prostate cancer.高危前列腺癌患者的影像学评估。
Nat Rev Urol. 2015 Nov;12(11):617-28. doi: 10.1038/nrurol.2015.242. Epub 2015 Oct 20.
9
Reduced acquisition times in whole body bone scintigraphy using a noise-reducing Pixon®-algorithm-a qualitative evaluation study.使用降噪 Pixon®算法降低全身骨闪烁显像采集时间:一项定性评估研究。
EJNMMI Res. 2015 Dec;5(1):48. doi: 10.1186/s13550-015-0127-x. Epub 2015 Sep 16.
10
When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer.初诊前列腺癌患者何时行正电子发射断层扫描/计算机断层扫描或放射性核素骨扫描。
Cancer Manag Res. 2013 Jun 25;5:123-31. doi: 10.2147/CMAR.S34685. Print 2013.